Zhongchao Inc. reports developments as a Cayman Islands holding company whose PRC operating entities provide platform-based healthcare information, education, training, patient management, and internet healthcare services in China. Its updates center on cancer and major-disease services, including the MDMOOC professional education platform, Zhongxin patient management programs, Zhixun Internet Hospital, and Sunshine Health Forums.
Recurring news themes include patient aid and medication assistance projects, disease management models for oncology and autoimmune conditions, healthcare professional education platforms, content partnerships for cancer education, and ordinary-share consolidations tied to Nasdaq listing compliance for ZCMD Class A ordinary shares.
On July 10, 2020, Zhongchao Inc. (NASDAQ: ZCMD) announced the co-organization of a virtual panel session on gastroenterology, part of the China-Russia-Near East Academic Dialogue. Held on June 30, 2020, the event featured prominent gastroenterologists from China, Russia, Lebanon, and Jordan and attracted over 36,000 participants. This follows another successful session on neonatology with 23,000 attendees. Chairman Weiguang Yang emphasized the importance of digital transformation in healthcare amidst COVID-19, expressing commitment to future collaborative events.
Zhongchao Inc. (NASDAQ: ZCMD) has officially launched a new line of patient management services branded as Zhongxun. This initiative expands its existing platforms, including MDMOOC and Sunshine Health Forums. The services will integrate online and offline approaches, collaborating with hospitals, pharmacies, and insurance companies to provide comprehensive patient management solutions. Chairman James Yang anticipates that Zhongxun will drive significant future growth, leveraging China's expanding healthcare market and technology advancements.